CoChat
Sign Up
Cited by 236Schizophrenia research and treatmentAdvanced Neuroimaging Techniques and ApplicationsMental Health and Psychiatry

Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage

Open access
Kochunov, P., Hong, L. E.·2014·Schizophrenia Bulletin
DOI 10.1093/schbul/sbu070PMC PMC4059450
Open this paper in CoChat — free accountOpen PDF

Abstract

Schizophrenia is a disorder of cerebral disconnectivity whose lifetime course is modeled as both neurodevelopmental and neurodegenerative. The neurodevelopmental models attribute schizophrenia to alterations in the prenatal-to-early adolescent development. The neurodegenerative models identify progressive neurodegeneration as its core attribute. Historically, the physiology, pharmacology, and treatment targets in schizophrenia were conceptualized in terms of neurons, neurotransmitter levels, and synaptic receptors. Much of the evidence for both models was derived from studies of cortical and subcortical gray matter. We argue that the dynamics of the lifetime trajectory of white matter, and the consistency of connectivity deficits in schizophrenia, support white matter integrity as a promising phenotype to evaluate the competing evidence for and against neurodevelopmental and neurodegenerative heuristics. We develop this perspective by reviewing normal lifetime trajectories of white and gray matter changes. We highlighted the overlap between the age of peak of white matter development and the age of onset of schizophrenia and reviewed findings of white matter abnormalities prior to, at the onset, and at chronic stages of schizophrenia. We emphasized the findings of reduced white matter integrity at the onset and findings of accelerated decline in chronic stages, but the developmental trajectory that precedes the onset is largely unknown. We propose 4 probable lifetime white matter trajectory models that can be used as the basis for separation between the neurodevelopmental and neurodegenerative etiologies. We argue that a combination of the cross-sectional and longitudinal studies of white matter integrity in patients may be used to bridge the neurodevelopment and degeneration heuristics to advance schizophrenia research.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/schbul/sbu070

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 72

  1. [1]1. Weinberger DR, Lipska BK. Cortical maldevelopment, antipsychotic drugs, and schizophrenia: a search for common ground. Schizophr Res . 1995;16:87-110.
  2. [4]4. Rapoport JL, Addington AM, Frangou S, Psych MR. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry . 2005;10:434-449.
  3. [5]5. Murray RM, O'Callaghan E, Castle DJ, Lewis SW . A neurodevelopmental approach to the classification of schizophrenia. Schizophr Bull . 1992;18:319-332.
  4. [6]6. Knoll JLt, Garver DL, Ramberg JE, Kingsbury SJ, Croissant D, McDermott B. Heterogeneity of the psychoses: is there a neurodegenerative psychosis? Schizophr Bull . 1998;24:365-379.
  5. [7]7. Anderson JE, O'Donnell BF, McCarley RW, Shenton ME. Progressive changes in schizophrenia: do they exist and what do they mean? Restor Neurol Neurosci . 1998;12:175-184.
  6. [8]8. Friston KJ, Frith CD. Schizophrenia: a disconnection syndrome? Clin Neurosci . 1995;3:89-97.
  7. [9]9. Repovs G, Csernansky JG, Barch DM. Brain network connectivity in individuals with schizophrenia and their siblings. Biol Psychiatry . 2011;69:967-973.
  8. [11]11. Lillrank SM, Lipska BK, Weinberger DR. Neurodevelopmental animal models of schizophrenia. Clin Neurosci . 1995;3:98-104.
  9. [12]12. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res . 1982;17:319-334.
  10. [13]13. Pantelis C, Yücel M, Wood SJ, et al. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull . 2005;31:672-696.
  11. [14]14. Sun D, Phillips L, Velakoulis D, et al. Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr Res . 2009;108:85-92.
  12. [15]15. Rapoport JL, Addington A, Frangou S. The neurodevelopmental model of schizophrenia: what can very early onset cases tell us? Curr Psychiatry Rep . 2005;7:81-82.
  13. [16]16. DeLisi LE, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res . 1997;74:129-140.
  14. [17]17. Woods BT. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am J Psychiatry . 1998;155:1661-1670.
  15. [18]18. Lieberman JA. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry . 1999;46:729-739.
  16. [19]19. Lieberman J, Chakos M, Wu H, et al. Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry . 2001;49:487-499.
  17. [20]20. McCarley RW, Wible CG, Frumin M, et al. MRI anatomy of schizophrenia. Biol Psychiatry . 1999;45:1099-1119.
  18. [21]21. Pantelis C, Stuart GW , Nelson HE, Robbins TW , Barnes TR. Spatial working memory deficits in schizophrenia: relationship with tardive dyskinesia and negative symptoms. Am J Psychiatry . 2001;158:1276-1285.
  19. [22]22. Rimol LM, Nesvåg R, Hagler DJ Jr, et al. Cortical volume, surface area, and thickness in schizophrenia and bipolar disorder. Biol Psychiatry . 2012;71:552-560.
  20. [23]23. Andreasen NC. The lifetime trajectory of schizophrenia and the concept of neurodevelopment. Dialogues Clin Neurosci . 2010;12:409-415.
  21. [24]24. Jeste DV , Wolkowitz OM, Palmer BW . Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia. Schizophr Bull . 2011;37:451-455.
  22. [25]25. McGlashan TH. The Chestnut Lodge follow-up study. II. Long-term outcome of schizophrenia and the affective disorders. Arch Gen Psychiatry . 1984;41:586-601.
  23. [26]26. McGlashan TH. The Chestnut Lodge follow-up study. I. Follow-up methodology and study sample. Arch Gen Psychiatry . 1984;41:573-585.
  24. [27]27. Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J . 2005;150:1115-1121.
  25. [28]28. Kirkpatrick B. Schizophrenia as a systemic disease. Schizophr Bull . 2009;35:381-382.
  26. [29]29. Kirkpatrick B, Messias E, Harvey PD, Fernandez-Egea E, Bowie CR. Is schizophrenia a syndrome of accelerated aging? Schizophr Bull . 2008;34:1024-1032.
  27. [30]30. Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW. Mapping cortical change across the human life span. Nat Neurosci . 2003;6:309-315.
  28. [33]33. Kochunov P, Williamson DE, Lancaster J, et al. Fractional anisotropy of water diffusion in cerebral white matter across the lifespan. Neurobiol Aging . 2012;33:9-20.
  29. [36]36. Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, Neufeld AH. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage . 2003;20:1714-1722.
  30. [37]37. Song SK, Y oshino J, Le TQ, et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage . 2005;26:132-140.
  31. [38]38. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A . 2000;97:11050-11055.
  32. [39]39. Lerch JP, Evans AC. Cortical thickness analysis examined through power analysis and a population simulation. Neuroimage . 2005;24:163-173.
  33. [40]40. Huttenlocher PR, Dabholkar AS. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol . 1997;387:167-178.
  34. [41]41. Salthouse TA. When does age-related cognitive decline begin? Neurobiol Aging . 2009;30:507-514.
  35. [42]42. Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW. Mapping cortical change across the human life span. Nat Neurosci . 2003;6:309-315.
  36. [43]43. Cancelliere A, Mangano FT, Air EL, et al. DTI values in key white matter tracts from infancy through adolescence. AJNR Am J Neuroradiol . 2013;34:1443-1449.
  37. [44]44. Flechsig P . Developmental (myelogenetic) localisation of the cerebral cortex in the human. Lancet . 1901;158:1027-1030.
  38. [45]45. Kochunov P, Glahn DC, Lancaster J, et al. Blood pressure and cerebral white matter share common genetic factors in Mexican Americans. Hypertension . 2011;57:330-335.
  39. [46]46. Westlye LT, Walhovd KB, Dale AM, et al. Differentiating maturational and aging-related changes of the cerebral cortex by use of thickness and signal intensity. Neuroimage . 2010;52:172-185.
  40. [47]47. Kochunov P, Glahn DC, Lancaster J, et al. Fractional anisotropy of cerebral white matter and thickness of cortical gray matter across the lifespan. Neuroimage . 2011;58:41-49.
  41. [48]48. Kochunov P, Williamson DE, Lancaster J, et al. Fractional anisotropy of water diffusion in cerebral white matter across the lifespan. Neurobiol Aging . 2012;33:9-20.
  42. [50]50. Wright S, Kochunov P, Chiappelli J, et al. Accelerated white matter aging in schizophrenia: role of white matter blood perfusion. Neurobiol Aging . 2014. doi:10.1016/j. neurobiolaging.2014.02.016. · DOI
  43. [52]52. Hof PR, Haroutunian V, Friedrich VL Jr, et al. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry . 2003;53:1075-1085.
  44. [53]53. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res . 2004;67:269-275.
  45. [54]54. Mitkus SN, Hyde TM, Vakkalanka R, et al. Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia. Schizophr Res . 2008;98:129-138.
  46. [55]55. Uranova N, Orlovskaya D, Vikhreva O, et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull . 2001;55:597-610.
  47. [57]57. V ostrikov V , Uranova N. Age-related increase in the number of oligodendrocytes is dysregulated in schizophrenia and mood disorders. Schizophr Res Treatment . 2011;2011:174689.
  48. [58]58. Uranova NA, Vikhreva OV, Rachmanova VI, Orlovskaya DD. Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study. Schizophr Res Treatment . 2011;2011:325789.
  49. [59]59. Woods BT, Yurgelun-Todd D, Goldstein JM, Seidman LJ, Tsuang MT. MRI brain abnormalities in chronic schizophrenia: one process or more? Biol Psychiatry . 1996;40:585-596.
  50. [60]60. Turetsky B, Cowell PE, Gur RC, Grossman RI, Shtasel DL, Gur RE. Frontal and temporal lobe brain volumes in schizophrenia. Relationship to symptoms and clinical subtype. Arch Gen Psychiatry . 1995;52:1061-1070.
  51. [61]61. Breier A, Buchanan RW , Elkashef A, Munson RC, Kirkpatrick B, Gellad F. Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch Gen Psychiatry . 1992;49:921-926.
  52. [19]19. resonance imaging study early in schizophrenia. Arch Gen Psychiatry . 2003;60:585-594.
  53. [63]63. Lim KO, Hedehus M, Moseley M, de Crespigny A, Sullivan EV, Pfefferbaum A. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry . 1999;56:367-374.
  54. [66]66. Friedman JI, Tang C, Carpenter D, et al. Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients. Am J Psychiatry . 2008;165:1024-1032.
  55. [67]67. Glahn DC, Curran JE, Winkler AM, et al. High dimensional endophenotype ranking in the search for major depression risk genes. Biol Psychiatry . 2012;71:6-14.
  56. [68]68. Nazeri A, Chakravarty MM, Felsky D, et al. Alterations of superficial white matter in schizophrenia and relationship to cognitive performance. Neuropsychopharmacology . 2013;38:1954-1962. doi:10.1038/npp.2013.93. · DOI
  57. [69]69. Alba-Ferrara LM, de Erausquin GA. What does anisotropy measure? Insights from increased and decreased anisotropy in selective fiber tracts in schizophrenia. Front Integr Neurosci . 2013;7:9.
  58. [70]70. Perez-Iglesias R, Tordesillas-Gutierrez D, McGuire PK, et al. White matter integrity and cognitive impairment in first-episode psychosis. Am J Psychiatry . 2011;167:451-458.
  59. [71]71. Karlsgodt KH, Niendam TA, Bearden CE, Cannon TD. White matter integrity and prediction of social and role functioning in subjects at ultra-high risk for psychosis. Biol Psychiatry . 2009;66:562-569.
  60. [72]72. Carletti F , Woolley JB, Bhattacharyya S, et al. Alterations in white matter evident before the onset of psychosis. Schizophr Bull . 2012;38:1170-1179.
  61. [73]73. Bloemen OJ, de Koning MB, Schmitz N, et al. White-matter markers for psychosis in a prospective ultra-high-risk cohort. Psychol Med . 2010;40:1297-1304.
  62. [74]74. Szeszko PR, Ardekani BA, Ashtari M, et al. White matter abnormalities in first-episode schizophrenia or schizoaffective disorder: a diffusion tensor imaging study. Am J Psychiatry . 2005;162:602-605.
  63. [75]75. Perez-Iglesias R, Tordesillas-Gutierrez D, Barker GJ, et al. White matter defects in first episode psychosis patients: a voxelwise analysis of diffusion tensor imaging. Neuroimage . 2013;49:199-204.
  64. [76]76. Peters BD, Blaas J, de Haan L. Diffusion tensor imaging in the early phase of schizophrenia: what have we learned? J Psychiatr Res . 2013;44:993-1004.
  65. [77]77. Nazeri A, Chakravarty MM, Felsky D, et al. Alterations of superficial white matter in schizophrenia and relationship to cognitive performance. Neuropsychopharmacology . 2013;38:1954-1962.
  66. [78]78. Kubicki M, McCarley R, Westin CF, et al. A review of diffusion tensor imaging studies in schizophrenia. J Psychiatr Res . 2007;41:15-30.
  67. [79]79. Hubl D, Koenig T, Strik W , et al. Pathways that make voices: white matter changes in auditory hallucinations. Arch Gen Psychiatry . 2004;61:658-668.
  68. [80]80. Jones DK, Catani M, Pierpaoli C, et al. Age effects on diffusion tensor magnetic resonance imaging tractography measures of frontal cortex connections in schizophrenia. Hum Brain Mapp . 2006;27:230-238.
  69. [81]81. Kochunov P, Chiappelli J, Wright S, et al. Multimodal white matter imaging to investigate reduced fractional anisotropy and its age-related decline in schizophrenia. Psychiatry Res Neuroimag . In press.
  70. [82]82. Kubicki M, Styner M, Bouix S, et al. Reduced interhemispheric connectivity in schizophrenia-tractography based segmentation of the corpus callosum. Schizophr Res . 2008;106:125-131.
  71. [83]83. Reis Marques T, Taylor H, Chaddock C, et al. White matter integrity as a predictor of response to treatment in first episode psychosis. Brain . 2014;137:172-182.
  72. [84]84. Hadley JA, Nenert R, Kraguljac NV, et al. Ventral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia. Neuropsychopharmacology . 2014;39:1020-1030.

Cited by

Sorted by citations

Authors
Kochunov, P., & Hong, L. E.
Affiliations
University of Maryland, Baltimore (US)
Corresponding author
Kochunov, P.
ORCID
Kochunov, P.
Venue
Schizophrenia Bulletin
Publisher
Oxford University Press (OUP)
Published
2014-05-27
Volume
40
Issue
4
Pages
721-728
ISSN
  • 0586-7614 (ISSN-L)
  • 1745-1701
DOI
10.1093/schbul/sbu070
PMC
PMC4059450
OpenAlex
W2109435900
Cited by
236
References
10
Citations by year
2026: 17 · 2025: 18 · 2024: 18 · 2023: 19 · 2022: 28 · 2021: 17 · 2020: 23 · 2019: 20 · 2018: 18 · 2017: 20 · 2016: 24 · 2015: 12 · 2014: 2
FWCI
2.68
Type
journal article
Language
en
Open access
Locations
  • Schizophrenia Bulletin (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute of Mental Health (R01MH085646)
  • National Institute on Drug Abuse (R01DA027680)
  • National Institute of Biomedical Imaging and Bioengineering (R01EB015611)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced Neuroimaging Techniques and Applications
  • Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords
schizophrenia, white matter integrity
MeSH terms
Brain, Humans, Longitudinal Studies, Models, Biological, Neural Pathways, Schizophrenia, Diffusion Tensor Imaging, White Matter, Gray Matter

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review